Clinical trial
Effects of Oxygen Supply on Hypoxic Pulmonary Vasoconstriction and Lung Collapse After Lung Isolation in Thoracic Surgery - a Prospective, Randomized Clinical Trial
Name
1051/2023
Description
The goal of this randomized clinical trial is to compare a liberal versus restrictive oxygen supply (fraction of inspired oxygen, FiO2) strategy in patients scheduled for thoracic surgery requiring one-lung ventilation during lung isolation. The primary and secondary outcome parameters are:
* oxygenation of the blood after 30 minutes of one-lung ventilation, assessed by PaO2/FiO2 ratio
* time to lung collapse after start of one-lung ventilation
Participants in the control goup will receive an oxygen content of 100% before lung isolation, which will be subsequently decreased to achieve normoxia or mild hyperoxia (PaO2 of 75-120 mmHg).
The intervention group will receive the previous, during two-lung ventilation set, oxygen content and after lung isolation oxygen supply will be increased to secure adequate oxygenation of the blood (PaO2 75-120 mmHg) during one-lung ventilation.
The investigators hypothesize, that a higher fraction of inspired oxygen may impede hypoxic pulmonary vasoconstriction of the collapsed lung and thus decrease overall oxygenation performance during one-lung ventilation. Secondary endpoint will be the time to lung collapse, as a lower fraction of inspired oxygen and thus a higher nitrogen content may impede lung collapse.
Trial arms
Trial start
2023-07-19
Estimated PCD
2024-03-07
Trial end
2024-03-07
Status
Completed
Treatment
restrictive oxygen supply
Oxygen supply will be limited to guarantee normoxia at the beginning of OLV.
Arms:
low oxygen: incremental FiO2 titration
liberal oxygen supply
Oxygen supply will be maximized to 100% at the beginning of OLV
Arms:
high oxygen: decremental FiO2 titration
Size
55
Primary endpoint
oxygenation of the blood
Primary outcome timepoint is defined at 30 minutes after start of OLV
Eligibility criteria
Inclusion Criteria:
* Male and female subjects ≥ 18 years
* Elective thoracic surgery requiring OLV
* American Society of Anesthesiologists physical status classification I-III
* Written informed consent
Exclusion Criteria:
* Emergency surgery
* Female subjects known to be pregnant
* Known participation in another interventional clinical trial
* Empyema evacuation or signs of pulmonary infection
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['NA'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'interventionModelDescription': 'non-blinded, randomized, controlled trial', 'primaryPurpose': 'TREATMENT', 'maskingInfo': {'masking': 'SINGLE', 'maskingDescription': 'Study participants will be randomized after induction of general anesthesia and thus are not aware of the treatment arm, which solely differs at the time of lung isolation.', 'whoMasked': ['PARTICIPANT']}}, 'enrollmentInfo': {'count': 55, 'type': 'ACTUAL'}}
Updated at
2024-03-12
1 organization
2 products
3 indications
Organization
Medical University InnsbruckProduct
Restrictive Oxygen SupplyIndication
Mechanical VentilationIndication
Thoracic Surgical ProceduresIndication
One-lung ventilationProduct
Liberal oxygen supply